Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: A quantitative review.

A meta-analysis was used to integrate the research literature on the treatment of obsessive-compulsive disorder. Antidepressants, such as clomipramine, and behavior therapy have produced appreciable changes in obsessive-compulsive and depressive symptoms. Patients with obsessions who did not suffer from compulsions have responded less to treatment. No follow-up data have been available for clomipramine, but the benefits of behavior therapy have been shown to be stable at follow-up. Ratings of improvement by assessors have been higher than ratings made by patients. The effects of tricyclic medication and exposure therapies have not significantly differed, but both have proven significantly superior to nonspecific treatment programs. There is a need for a large, randomized comparison of clomipramine and exposure that includes adequate follow-up of subjects after treatment has concluded. (PsycINFO Database Record (c) 2010 APA, all rights reserved)